Hikma Pharmaceuticals Plc Director/PDMR Shareholding (6668Q)
22 Giugno 2020 - 12:20PM
UK Regulatory
TIDMHIK
RNS Number : 6668Q
Hikma Pharmaceuticals Plc
22 June 2020
Hikma Pharmaceuticals PLC
Notification and public disclosure of transactions by persons
discharging managerial responsibilities
Said Darwazah
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Said Darwazah
2 Reason for the notification
a) Position/status Executive Chairman
b) Initial notification Initial notification
/Amendment
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
a) Description of Description: Ordinary shares of 10 pence each
the financial ID Code: GB00B0LCW083
instrument, type
of instrument
and identification
code
b) Nature of the Extension of existing pledge by Darhold Limited
transaction of 2,000,000 Ordinary Shares of 10 pence each
in Hikma Pharmaceuticals PLC in support of a
loan, in favour of EFG Bank. Darhold Limited
is defined as a Person Closely Associated with
the Executive Chairman, who is a director and
shareholder of Darhold.
c) Price(s) and Price(s): GBP0.00p
volume(s) Volume(s): 2,000,000
d) Aggregated information Aggregated volume: 2,000,000
Price: GBP0.00p
e) Date of the transaction 22 June 2020
f) Place of the Amman
transaction
Mazen Darwazah
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Mazen Darwazah
2 Reason for the notification
a) Position/status Executive Vice Chairman
b) Initial notification Initial notification
/Amendment
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
a) Description of Description: Ordinary shares of 10 pence each
the financial ID Code: GB00B0LCW083
instrument, type
of instrument
and identification
code
b) Nature of the Extension of existing pledge by Darhold Limited
transaction of 2,000,000 Ordinary Shares of 10 pence each
in Hikma Pharmaceuticals PLC in support of a
loan, in favour of EFG Bank. Darhold Limited
is defined as a Person Closely Associated with
the Executive Vice Chairman, who is a director
and shareholder of Darhold.
c) Price(s) and Price(s): GBP0.00p
volume(s) Volume(s): 2,000,000
d) Aggregated information Aggregated volume: 2,000,000
Price: GBP0.00p
e) Date of the transaction 22 June 2020
f) Place of the Amman
transaction
Mohammed 'Ali' Al-Husry
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Mohammed 'Ali' Al-Husry
2 Reason for the notification
a) Position/status Non-Executive Director
b) Initial notification Initial notification
/Amendment
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
a) Description of Description: Ordinary shares of 10 pence each
the financial ID Code: GB00B0LCW083
instrument, type
of instrument
and identification
code
b) Nature of the Extension of existing pledge by Darhold Limited
transaction of 2,000,000 Ordinary Shares of 10 pence each
in Hikma Pharmaceuticals PLC in support of a
loan, in favour of EFG Bank. Darhold Limited
is defined as a Person Closely Associated with
the Non-Executive Director, who is a director
and shareholder of Darhold.
c) Price(s) and Price(s): GBP0.00p
volume(s) Volume(s): 2,000,000
d) Aggregated information Aggregated volume: 2,000,000
Price: GBP0.00p
e) Date of the transaction 22 June 2020
f) Place of the Amman
transaction
Peter Speirs
Company Secretary, responsible for releasing this
announcement
+44 (0) 20 7399 2760
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHBGGDLCBDDGGD
(END) Dow Jones Newswires
June 22, 2020 06:20 ET (10:20 GMT)
Grafico Azioni Hikma Pharmaceuticals (LSE:HIK)
Storico
Da Feb 2024 a Mar 2024
Grafico Azioni Hikma Pharmaceuticals (LSE:HIK)
Storico
Da Mar 2023 a Mar 2024